Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2018
SIETES contiene 92588 citas

 
 
 1 a 20 de 86 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Girard TD , Exline MC , Carson SS , Hough CL , Rock P , Gong MN , Douglas IS , Malhotra A , Owens RL , Feinstein DJ , Khan B , Pisani MA , Hyzy RC , Schmidt GA , Schweickert WD , Hite RD , Bowton DL , Masica AL , Thompson JL , Chandrasekhar R , Pun BT , Strength C , Boehm LM , Jackson JC , Pandharipande PP , Brummel NE , Hughes CG , Patel MB , Stollings JL , Bernard GR , Dittus RS , Ely EW , for the MIND-USA Investigators. Haloperidol and ziprasidone for treatment of delirium in vritical illness. N Engl J Med 2018:22 de octubre. [Ref.ID 102838]
2. Cita con resumen
Laatikainen O, Mietttunen J, Sneck S, Lehtiniemi H, Tenhunen O, Turpeinen M. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. Eur J Clin Pharmacol 2017;73:1539-49. [Ref.ID 102145]
3. Cita con resumen
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic pot: not your grandfathers marijuana. Trends Pharmacol Sci 2017;38:257-76. [Ref.ID 101989]
4. Cita con resumen
Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, Sanderson C, Hardy J, Le B, Eckermann S, McCaffrey N, Devilee L, Fazekas B, Hill M, Currow DC. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med 2017;177:34-42. [Ref.ID 101343]
5.Enlace a cita original Cita con resumen
Pasina L, Zanotta D, Puricelli S, Bonoldi G. Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series. Eur J Clin Pharmacol 2016;72:641-3. [Ref.ID 100252]
6. Cita con resumen
Herziq SJ, Rothberg MB, Guess JR, Stevens JP, Marshall J, Gurwitz JH, Marcantonio ER. Antipsychotic use in hospitalized adults: rates, indications, and predictors. J Am Geriatr Soc 2016;64:299-305. [Ref.ID 100051]
7. Cita con resumen
Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid - Related illnesses and deahts. N Engl J Med 2015;373:103-7. [Ref.ID 99338]
8. Cita con resumen
Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]
9. Cita con resumen
Anónimo. Néfopam: un bilan français. Prescrire 2013;33:825. [Ref.ID 96494]
10.Tiene citas relacionadas Cita con resumen
Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW, on behalf of the National Joint Registry for England Wales and Northern Ireland. 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 2013;382:1097-104. [Ref.ID 96311]
11.Tiene citas relacionadas Cita con resumen
Issa K, Mont MA. Total hip replacement: mortality and risks. Lancet 2013;382:1074-6. [Ref.ID 96310]
12. Cita con resumen
Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, Jackson J, Perkins GD, McAuley DF. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 2013;1:515-23. [Ref.ID 95894]
13. Cita con resumen
Anónimo. Ranolazine: hallucinations. Prescrire 2012;32:917. [Ref.ID 94200]
14.
Young J, Meagher D, MacLullich A. Cognitive assessment of older people. BMJ 2011;343:527-31. [Ref.ID 91463]
15.
Sanders RD, Pandharipande PP, Davidson AJ, Ma D, Maze M. Anticipating and managing postoperative delirium and cognitive decline in adults. BMJ 2011;343:197-200. [Ref.ID 90966]
16.Tiene citas relacionadas
van Eijk MM, van Gool W, Slooter AJC. Cholinesterase inhibitor treatment in patients with delirium. Authors' reply. Lancet 2011;377:901. [Ref.ID 90324]
17.Tiene citas relacionadas
Opdam FL, Oleksik AM, Westendorp RGJ. Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011;377:900-1. [Ref.ID 90323]
18.Tiene citas relacionadas
Berg RMG, Moller K. Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011;377:900. [Ref.ID 90322]
19.Tiene citas relacionadas
Gusmao-Flores D, Chalhub RA, Quarantini LC. Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011;377:899-900. [Ref.ID 90321]
20.Tiene citas relacionadas
de Pont A-CJM, van Geer MA. Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011;377:899. [Ref.ID 90320]
Seleccionar todas
 
 1 a 20 de 86 siguiente >>